Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010, Lancet, vol.380, issue.9859, pp.2197-223, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00827610
Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project, Acta Psychiatr Scand, vol.112, issue.6, pp.425-458, 2005. ,
Prevalence and correlates of the proposed DSM-5 diagnosis of chronic depressive disorder, J Affect Disord, vol.139, issue.2, pp.172-80, 2012. ,
Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features, J Affect Disord, vol.87, issue.1, pp.43-55, 2005. ,
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report, Am J Psychiatry, vol.163, issue.11, pp.1905-1922, 2006. ,
Evaluation of outcomes with citalopram for depression using measurementbased care in STAR*D: implications for clinical practice, Am J Psychiatry, vol.163, issue.1, pp.28-40, 2006. ,
Society for Biological Psychiatry and Neuropsychopharmacology task force: formal consensus for the prescription of depot antipsychotics, Encéphale, vol.39, issue.4, pp.189-203, 2013. ,
World Federation of Societies of biological psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders, World J Biol Psychiatry, vol.14, issue.5, pp.334-85, 2013. ,
Practice guideline for the treatment of patients with major depressive disorder. In: American psychiatric association, 2010. ,
Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the Management of Adults with major depressive disorder: section 3. Pharmacological treatments, Can J Psychiatr, vol.61, issue.9, pp.540-60, 2016. ,
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines, J Psychopharmacol (Oxford), vol.29, issue.5, pp.459-525, 2015. ,
, Depression: The Treatment and Management of Depression in Adults (Updated Edition), National Institute for Health and Clinical Excellence: Guidance, 2010.
Comorbid anxiety and depression, J Clin Psychiatry, vol.66, issue.8, pp.22-31, 2005. ,
Escitalopram therapy for major depression and anxiety disorders, Ann Pharmacother, vol.41, issue.10, pp.1583-92, 2007. ,
The treatment of generalized anxiety disorder in patients with depressive symptomatology, J Clin Psychiatry, vol.54, pp.20-23, 1993. ,
Generalized anxiety disorder: prevalence, burden, and cost to society, Depress Anxiety, vol.16, issue.4, pp.162-71, 2002. ,
Antidepressants in the treatment of agoraphobia and obsessive-compulsive disorder, Compr Psychiatry, vol.24, issue.3, pp.278-84, 1983. ,
A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety, J Clin Psychiatry, vol.59, issue.3, pp.123-130, 1998. ,
Mirtazapine in major depression with comorbid generalized anxiety disorder, J Clin Psychiatry, vol.60, issue.7, pp.446-454, 1999. ,
Mirtazapine treatment of social phobia in women: a randomized, doubleblind, placebo-controlled study, J Clin Psychopharmacol, vol.25, issue.6, pp.580-583, 2005. ,
Treatment of posttraumatic stress disorder: the impact of paroxetine, Psychopharmacol Bull, vol.37, issue.1, pp.76-88, 2003. ,
Obsessive-compulsive disorder has a reduced placebo (and antidepressant) response compared to other anxiety disorders: a meta-analysis, J Affect Disord, vol.218, pp.217-243, 2017. ,
Citalopram for treatment-resistant obsessive-compulsive disorder -Eur Psychiatry, vol.14, pp.101-107, 1999. ,
A doubleblind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder, J Clin Psychopharmacol, vol.31, issue.6, pp.763-771, 2011. ,
Preliminary experience with adjunctive quetiapine in patients receiving selective serotonin reuptake inhibitors, Depress Anxiety, vol.19, issue.2, pp.121-127, 2004. ,
Treatment of residual anxiety symptoms with adjunctive aripiprazole in depressed patients taking selective serotonin reuptake inhibitors, J Affect Disord, vol.86, issue.1, pp.99-104, 2005. ,
A prospective randomized single-blind, multicenter trial comparing the efficacy and safety of paroxetine with and without quetiapine therapy in depression associated with anxiety, Int J Psychiatry Clin Pract, vol.8, issue.4, pp.205-216, 2004. ,
Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study, Depress Anxiety, vol.24, issue.7, pp.487-94, 2007. ,
Treating comorbid anxiety and depression: psychosocial and pharmacological approaches, World J Psychiatry, vol.5, issue.4, pp.366-78, 2015. ,
Internet-based self-help interventions for depression in routine care-reply, JAMA Psychiatry, vol.74, issue.8, p.853, 2017. ,
Treatment of co-occurring depression and substance dependence: using meta-analysis to guide clinical recommendations, Psychiatr Ann, vol.38, issue.11, p.128505, 2008. ,
Assessment and treatment of mood disorders in the context of substance abuse, Dialogues Clin Neurosci, vol.17, issue.2, pp.181-90, 2015. ,
A review of the literature of mirtazapine in co-occurring depression and an alcohol use disorder, J Addict Behav Ther Rehabil, vol.5, issue.4, 2016. ,
Personality disorder and the outcome of depression: meta-analysis of published studies, Br J Psychiatry, vol.188, pp.13-20, 2006. ,
A systematic approach to pharmacotherapy for geriatric major depression, Clin Geriatr Med, vol.30, issue.3, pp.517-551, 2014. ,
Mirtazapine vs. paroxetine study group. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients, Am J Geriatr Psychiatry, vol.10, issue.5, pp.541-50, 2002. ,
Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant, Ther Adv Psychopharmacol, vol.6, issue.2, pp.99-144, 2016. ,
Demographic and clinical factors associated with different antidepressant treatments: a retrospective cohort study design in a UK psychiatric healthcare setting, BMJ Open, vol.8, issue.9, p.22170, 2018. ,
Treasure Island (FL): StatPearls Publishing, StatPearls [Internet, 2018. ,